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Summary 
Combining the engineering principles of system dynamics and control theory with 
biological applications of nanoparticle synthesis and organ-on-a-chip, this work aims to 
advance these areas of research by developing precision control systems for high-
throughput synthesis and high-precision sampling, respectively.  A high-precision 
feedback pressure control system is developed to regulate the inlet pressure of microfluidic 
device, controlling the flow rate, for high precision nanoparticle synthesis. Mathematical 
derivation and experimental validation of the pressure system are discussed, with 
performance achieving less than 0.5% steady-state error for long term experimental 
duration (3 hours) and 0.3 second settling time. The pressure control system is integrated 
with the development of a parallelized microvortex array, designed to increase the 
multiplicity of microfluidic reactors in parallel for high-throughput nanoparticle 
manufacturing. Critical parameters (i.e., Reynolds number and precursor composition) to 
maintaining nanoparticle quality are assessed and factored into the development of fluidic 
circuit analog and computational fluid dynamic models. A robust 3-part device is fabricated 
for experimental validation of the design methodology. Lastly, the development of a 
tunable low-cost ($250) high-precision sampling device with settling times less than 0.3 
seconds, overshoot less than 2%, and zero steady-state error. Mathematical derivation of 
the controller and microvolumetric sampler constraints are discussed. The performance is 
experimentally validated through various input flow profiles. The entirety of this work can 
potentially advance not only the clinical translation of nanoparticles and biological 
sampling, but can additionally create high-precision experimentation in a variety of fields 
such as chemistry, life sciences, energy conversion, and defense.
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Chapter 1 Introduction 
A number of nanoparticles (NPs) have been developed for targeted delivery of 
therapeutic and imaging agents for the treatment and diagnosis of major diseases including 
cancer [1-3], cardiovascular disease [4, 5], diabetes [6, 7], and Alzheimer’s disease [8-10]. 
For a decade, only a small number of therapeutic and diagnostic (theranostic) NPs have 
been approved by the FDA [11, 12]. This low success rate in the “bench to bedside” 
translation is due in part to low reproducibility of desired properties or efficacies of 
developed nanomedicines in prescreening processes from in vitro testing to in vivo 
validation [13]. With pharmaceutical and biomedical industries acknowledging the 
challenges in scaling the production of NPs, there is a growing need for the development 
of robust technology for nanomedicine manufacturing [14-16]. The expanding field of 
microfluidics has been utilized in the development of NPs [17, 18], and developed as a 
platform to accelerate the translation of nanomedicines in response to this need [14]. 
Microfluidic platforms provide controllable flow patterns with tunable characteristic 
mixing times on the millisecond to microsecond scale that can be used for diffusive or 
convective mixing mechanisms [19-27]; however, these microfluidics-based NP syntheses 
have been largely limited to small-scale production of specific single component NPs with 
considerably less research on the scale-up applications [14-16]. Numerous studies have 
demonstrated that microfluidic synthesis produces narrower NP size distributions (i.e., 
high size uniformity) than those of conventional multi-step benchtop synthesis methods 
[28, 29], but the production rate remains restricted by a low throughput (up to a few grams 
per hour) [30, 31]. A recent approach using a turbulent impinging jet flow to synthesize 
polymeric NPs in a single device achieved a much higher production rate on the order of 
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kg/d [32]; however, optimization process of multicomponent NP synthesis in turbulent 
flow at macroscale remains impractical due to waste of costly precursors, and the effect of 
the high shear rate generated by turbulent flow on the stability or degradation of precursors 
remains to be investigated. This challenge underscores the importance of microfluidic 
parallelization technology that preserves the advantages of the microscale reaction by 
maintaining the characteristic mixing times on the millisecond to microsecond scale and 
the consistency of reactor conditions. Although several microfluidic parallelization 
approaches have been previously introduced using simple diffusive mixing to improve 
production rates from mg/d to g/d [15, 33-35], no reliable and practical approach has been 
established for scalable manufacturing of NPs to an industrially relevant level, such as 
attaining a production rate on the order of kg/d [12, 15, 36-38].  
This challenge is multifaceted but is largely due to the ambiguity that still surrounds 
the mechanisms of flow-induced NP formation and the reliance of microfluidic synthesis 
on conventional (open-loop) programmable syringe pumps. Microfluidic synthesis of NPs 
for parallelization rely on flow dynamic similarity across devices; however, to create a 
robust parallelized array, synthesis parameters affecting NP quality need to be optimized. 
Syringe pumps are not a robust methodology for scalable manufacturing of NPs due to 
several problems including the limited syringe size and the open-loop control-based 
operation that is unable to compensate for unexpected disturbances in the manufacturing 
process leading to non-robust production operations.  
In addition to addressing high-throughput nanoparticle synthesis, this work aims to 
apply engineering principles to biological systems with the development of a high-
precision sampling device for biological applications (e.g., organ-on-a-chip). 
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Discretization of biological samples, where specific volumes of a system are isolated for 
analysis, is an essential component of biological research for organ-on-a-chip [39-43], 
chemical syntheses [44, 45], and drug discovery [46-48]. Conventionally, experimental 
sampling, in a laboratory setting, relies on both the temporal and volumetric accuracy of 
the user, a potential source of error and variations across repeated experimentation. By 
applying the principles of control theory, a high-precision sampling device can be 
developed to eliminate the potential sources of error. This proposed device will help to 
automate the laboratory setting, allowing for more consistent and repeatable experiments.  
Based on the challenges presented and for the understanding of this work, the 
principles of NP synthesis, microfluidics, and control theory are discussed.   
1.1 Nanoparticle Synthesis 
A wide range of NPs have been developed including quantum dots [49], gold NPs [50, 
51], iron-oxide NPs [52], high-density lipoproteins[53], liposomes [54, 55], polymeric NPs 
[56, 57], and lipid-polymer NPs (LPNPs) [58]. NPs have been used in a variety of 
applications such as drug delivery, fluorescent labeling, magnetic resonance imaging 
(MRI), contrast enhancement, and tissue engineering [59, 60]. Primarily, this work focuses 
on the development of NPs for the delivery of targeted therapeutics. Liposomes (LNPs) 
have been used as drug carriers due to their biocompatibility, tunable surface chemistry, 
and ability to protect drugs from degradation [1, 61]. However, LNPs have a low drug 
encapsulation efficiency, thus limiting their effectiveness as drug carriers [62]. Polymeric 
NPs (PNPs) provide the advantage hydrophobic drug encapsulation [63] with high drug 
encapsulation efficiency [1, 64]. However, without PEGylation of PNPs (the incorporation 
of polyethylene glycol (PEG)), the hydrophobic PNPs are rapidly cleared from blood 
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circulation due to foreign body immune response [65]. PEGylation enables longer 
circulation time by reducing adverse immune responses (i.e. phagocytosis), lowers renal 
clearance by increasing particle size, increases solubility and particle stability as well as 
enhances charge chemistry of NPs for cellular uptake [66, 67].  
LPNPs were chosen as a platform for the development and optimization of the swirling 
microvortex reactor (SMR) because LPNPs leverage the advantages and mitigate the 
disadvantages of both polymeric NPs and liposomes (Figure 1.1) by incorporating a 
polymeric core within a PEGylated lipid shell [68]. Although this work primarily focuses 
on the development of LPNP, both PNPs and LNPs are still widely researched due to their 
unique properties and are examined on the developed platform. Briefly, LPNPs are 
conventionally synthesized by the rapid mixing of a polymer (e.g. poly(D,L-lactic-co-
glycolic acid) (PLGA)) in an organic solvent (e.g. acetonitrile) with a lipid (e.g. 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-Distearoylsn- glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000]  (DSPE-PEG)) in aqueous 
ethanol through a single or two-step process [69]. The resulting synthesized LPNPs can be 
evaluated for size uniformity with dynamic light scattering (DLS) and morphological 
characteristics with transmission electron microscopy (TEM). Due to the versatility of 
LPNPs, this work focuses on leveraging microfluidic devices to achieve high quality (i.e. 
low polydispersity) LPNPs at large-scale manufacturing. Synthesis of additional 
multicomponent NPs (e.g. engineered high-density lipoproteins, liposomes, and polymeric 
NPs) will be explored following the successful manufacturing of LPNPs. 
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Figure 1.1 Nanoparticle structure schematic. 
1.2 Microfluidic Nanoparticle Synthesis 
Over the last decade, there has been an increase in the development of microfluidic 
technologies for a variety of applications including life sciences [70], chemistry [71, 72], 
energy conversion [73], and defense [74]. Microfluidic devices are conventionally 
fabricated by a combination of photolithography and soft lithography. Photolithography 
involves the deposition of a photosensitive compound on a silicon wafer to create a mold. 
The compound is cured through high-intensity light exposure through a mask to produce a 
desired structure. Soft lithography involves applying and curing polydimethylsiloxane 
(PDMS) over the mold to imbed the desired structure. The resulting PDMS, containing the 
microfluidic structure, can be bonded to glass through oxidative plasma cleaning to create 
a finalized microfluidic device. 
Prior to the development of microfluidic technology, NP synthesis relied on “bench 
top” synthesis in which nanoprecipitation occurs through agitation from a stirrer or 
vortexer [75, 76]. Although a well-trained practitioner can batch produce NPs with 
homogenous size distributions, microfluidics provides a means for a controllable, well-
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characterized platform for consistent and continuous production of homogenous NPs. The 
first development of microfluidic technology to be applied to NP synthesis was “droplet” 
technology [77, 78]. The droplet is formed by the combination of insoluble solutions (e.g., 
water and oil) to create discretized droplets in a microfluidic channel. These discretized 
solutions move along the channel experiencing Dean’s flow, causing internal droplet flow 
and mixing of species within the droplet [79-81]. By having multiple reagents in a single 
droplet, rapid mixing can occur via continuous rotation of the droplet forming NPs. 
Microfluidics moved toward the development of continuous flow approaches with the 
development of hydrodynamic flow focusing [19, 82, 83], where mixing is diffusion 
dominated, generally long time constants, by minimizing the distance between the 
reagents. This pattern resolved the understanding of the fluid pattern by reducing the 
system to laminar flow, but it remains limited in the production rate of NPs (on the order 
of mg/hr).  
To overcome this limitation, convection based microfluidics were developed using 
microvortices [25, 84] and swirling flows [31]. Convective mixing (Re>100) allows for 
characteristic mixing times (1), where D represents the hydrodynamic diameter and 𝑣𝑣 
represents the fluid velocity, to remain smaller than diffusion times (2), where R represents 
the radius and 𝐷𝐷𝑐𝑐 represents the diffusion constant (on order of 1E-9). By increasing the 
velocity of the fluid (proportional to the Reynolds number) above (3), the convective 
mixing constant remains lower than the diffusive constant. Convective mixing therefor 
allows for a controlled, rapid mixing interface between NP precursor solutions coupled 
with hydrodynamic flow focusing of the precursors, allowing for further increase of NP 
production rates (on the order of g/hr). 














While this is a significant advancement in NP technology, the microfluidic device 
consists of only a singular module, thus limiting the overall production rate of NPs. To 
translate this technology to a sustainable manufacturing level, larger scale integration is 
required [13, 14, 18, 63]. To increase production, two methodologies are considered: scale-
up and parallelization. Scaling of a microfluidic device can achieve larger production; 
however, the advantage of microscale interactions allowing for improved polydispersity 
are potentially compromised, limiting the magnitude of scaling that can be achieved. 
Parallelization of microfluidics utilizes the standard manufacturing technique of 
simultaneous production while maintaining quality standards; however, requires a complex 
connective network to ensure reaction consistency.  
1.2.1 Microfluidic Parallelization 
Developments in scalable synthesis include the parallelization of droplet microfluidics 
[33, 85, 86] and hydrodynamic flow focusing microfluidics [15]. Work by Nisisako [33, 
87] demonstrates the increase in droplet production with the development of a 128 array of 
droplet microfluidics. This device demonstrated the use of a common inlet and outlet for 
all reactors, further explored by Mulligan [35], reducing the complexity of the design for 
operation while achieving simultaneous across all reactors. Romanowsky [34] 
demonstrated the development of a parallelized device through the use of a fluidic circuit 
analog [88], a critical tool to be predict flow consistency across all microfluidic reactors, 
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to be further explored with this work. These droplet microfluidic platforms, not necessarily 
designed for NP synthesis, demonstrated the development of parallelized microfluidic for 
industrial use, providing key tools for designing; however, remain inherently limited in 
production rate with a Reynolds number (Re≪1), a measure of flow viscous forces versus 
inertial forces. Lim [15] developed a parallelized platform of hydrodynamic flow focusing 
microfluidics combining 8 diffusive microfluidic devices for simultaneous polymeric NP 
synthesis. While this methodology can maintain homogeneous NP distribution across all 
devices, it remains limited in overall production of NPs (mg/hr at Re≪1) and the 
complexity of fabrication may potentially limit accessibility for industrial applications. 
Alternatively to parallelization, a ultra-high throughput (on the order of kg/d) of NPs by 
using turbulent flow was developed by Lim [32]. However, the high shear rates used in this 
turbulent flow can potentially cause instability or degradation of costly therapeutic agents 
potentially leading to unpredictable variations in NP properties and decreased therapeutic 
effect.  
Parallelization of convective microfluidic devices provides an unexplored opportunity 
for industrial scale synthesis (on the order of kg/hr) of multicomponent and multifunctional 
NPs. This work demonstrates the development of a parallelized microvortex array (PMA) 
for mass production of multicomponent therapeutic NPs by assessing and minimizing 
critical parameters of single-chip based synthesis with electrical fluidic analog modeling. 
1.3 Control Theory 
A combination of engineering and mathematics, control theory deals with the behavior 
of dynamic models based on the inputs to the system. A physical system (mechanical, 
fluidic, electrical, etc.) is first modeled and characterized with a set of governing 
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differential equations. Through the development of the model there is a loss of information, 
based on model assumptions, reducing model accuracy. Computationally evaluation of the 
model is used to predict output state variables based on input(s) to the system. Control 
theory can be utilized to shape the output to achieved desired performance characteristics 
(steady-state error, settling time, rise time, overshoot, etc.). Within control theory, there are 
two main divisions: open-loop control and closed-loop control. Open-loop control uses 
amplifier without feedback regulation to provide fast performance. However, it requires a 
well understood model for the dynamics of the complete system to provide high 
performance, not generally suited for nonlinear systems. Without the addition of feedback 
control, external disturbances cannot be mitigated, resulting in output oscillations and 
error. Closed-loop control performance is generally slower when compared to open-loop, 
but it provides the distinct advantage of minimizing/eliminating error from the reference 
signal through sensory feedback and remains a more robust system than open-loop control. 
External disturbances can be mitigated as the input to the system is continually updated 
based on the current state of the system relative to the desired reference. Dynamic models 
of the system do not need to be fully understood to implement closed-loop control for high 
performance, but controller design remains a large contributing factor to the stability of the 
system. Instability can occur in the system if the controller is poorly designed, leading to 
device malfunction and/or failure. Additionally, the design of linear controllers (e.g., 
proportional-integrative-derivative or lead/lag compensator) can be used to control 
nonlinear systems with the addition feedback control, allowing for simplistic controller 
architecture and design to complex systems.  
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1.3.1 Feedback Pressure Control 
In the context of this work, the method of fluid flow through microfluidic device is 
addressed by controlling the pressure differential across the device. Most microfluidic 
systems commonly use syringe pumps to create laminar flows within microfluidic devices. 
These pumps largely use step motors that may inadvertently generate pulsatile flow [89, 
90] and rely on an open-loop based operation which culminates in non-robust control of 
flow rates and the inability to respond to disturbances such as unexpected pressure variation 
[91]. The hydrodynamic resistance of microfluidics (order of 1E+15 𝑃𝑃𝑃𝑃 𝑠𝑠
𝑚𝑚3
) contributes to 
syringe pumps exhibiting long transient times [92, 93], potentially limiting applications.  
These syringe pump challenges have been partially addressed [94-99]; however, 
syringe pump systems remain limited by maximum syringe size and motor speed, 
potentially limiting manufacturing levels of NPs on parallelized microfluidics. In contrast 
to syringe pump systems, pressure modulation mechanisms provide variable reservoir sizes 
and high-pressurized sources, allowing for long-term duration at high-throughput, 
compared to syringe pumps. A variety of methodologies have been developed [100-105] 
to control flow, with applications to microfluidics.  
Here, a previously developed pressure modulation mechanism allowing long-term 
(duration of 15 hours) and high-speed control of microfluidic flows [106, 107] is analyzed. 
The inlet pressure of a microfluidic device was controlled by modulating a variable 
resistance and a flexible reservoir in a fluidic network between a fluidic precursor reservoir 
to a microfluidic device. The flexible reservoir allows for an alternative fluidic drainage to 
the microfluidic device, rapidly decreasing the inlet pressure to the device, which improves 
settling time by over 500% compared to single variable resistance only model. The flexible 
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reservoir contributes to both an increase and decrease in pressure as the tube is compressed 
and released. When maintaining constant pressure, it can be observed that the flexible 
reservoir contributes to the steady-state inlet pressure. During long-term experimentation, 
when the finite volume of the flexible reservoir is exhausted, by a completely compressed 
tube, the pressure can no longer be maintained and decreases. The system compensates by 
increasing the pressure with a pressurized reservoir, causing a large overshoot and releasing 
the reservoir. This process becomes cyclic leading to the generation of an oscillatory flow 
profile, undesirable for high precision microfluidic NP synthesis, maintained within 2.5% 
steady-state error (Figure 1.2).  
Although the coupled variable resistance and flexible reservoir allowed for rapid 
pressure variations, the inability to independently control may limit performance. To 
overcome this limitation and address the oscillatory behavior, this work will demonstrate 
a dual variable resistance model with independent control of compression/release of 
microfluidic tubing. This will eliminate the oscillatory flow present in the previous model 
and be coupled with the PMA for high-precision NP manufacturing. 
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Figure 1.2 Variable-Resistance and Variable Reservoir System Response. 
1.3.2 High-Precision Fluidic Sampling 
Discretization of biological samples, where specific volumes of a system are isolated 
for analysis, is an essential component of biological research for organ-on-a-chip [39-43, 
108], chemical syntheses [44, 45], and drug discovery [46-48]. Conventionally, 
experimental sampling, in a laboratory setting, relies on both the temporal and volumetric 
accuracy of the user, a potential source of error and variations across repeated 
experimentation. Microfluidics has become a recent approach to create an on-chip sample 
discretization using polydimethylsiloxane (PDMS) microfluidic values controlled through 
a pressure differential [103, 109-112]. Scalability of pressure controlled microfluidic 
valves has been demonstrated [79, 113, 114]; however, scaling the multiplicity of 
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discretized samples requires an increase in pressure controlled microfluidic valves and 
subsequent pressure regulation apparatus, increasing both overall complexity and expense.  
Microfluidic droplet generators [77, 78, 115-118] have demonstrated the ability to 
discretize fluidic samples by introducing an immiscible fluid to sample stream, segmenting 
the flow. The use of these devices requires continuous measurement devices (e.g., flow 
cytometer) for analysis and requires precision flow control for proper operation. 
Additionally, the scalability of droplet generators [33, 87] requires the complex 
understanding of parallelization [15, 34, 84] to design and ensure similarity between the 
multiplicity of sample volume and temporal differentials. Overcoming the necessity for 
continuous measurement devices, recent approaches have demonstrated nanoliter sampling 
[119] and picoliter sampling [120] to separate fluid into discretized wells. The 
mathematical complexity of the design and nanoliter and picoliter sampling may preclude 
the use with microfluidic systems (e.g., organ-on-a-chip devices), requiring system 
adaptability and microliter sampling [39-43, 108].  
The use of sampling can be used in a broad range of applications from measuring 
cellular expression to nanoparticle fluorescent. Critical to the analysis of organ-on-a-chip 
systems is the application of physiologically relevant drug/compound dosages. Improper 
dosages can lead to nonphysiologically relevant cellular responses or cause 
apoptosis/necrosis, skewing result. To better understand the dosage levels applied to the 
cells, sampling can be applied to map the dosage distribution overtime for both static and 
dynamics drug/compound dosages.  
This works presents an approach that integrates the use of feedback control with a 
tunable microvolumetric sampler device for a low-cost high-precision sampling 
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performance of biological micro-engineered systems. The motor dynamics are first 
modeled and experimentally validated the design of the rotational feedback controller with 
settling times less than 0.3 seconds, overshoot less than 2%, and zero steady-state error. 
The design constraints of the microvolumetric sampler are discussed, including 
multiplicity and size of sample effect on the controller implementation. After outlining the 
performance of the device, the microvolumetric sampler device is integrated with the 
organ-on-a-chip platform [43] to demonstrate the robust high-precision sampling of drug 
dosages. The analysis of cellular drug/compound loading is extended by computationally 
assessing the effect of membrane porosity. 
1.4 Technical Approach 
The primary purpose of this work is to develop a large scale parallelized array of 
swirling microvortex reactors (SMRs) coupled with high-precision pressure control for 
robust NP manufacturing. The resulting technology should accelerate the clinical 
translation of NPs by providing a means to mass produce high quality nanotherapeutics for 
testing. The following chapters will explore development of this technology by addressing 
the following goals: 
1. Development of a high precision, high-throughput, and long-term experimentation 
pressure control system of microfluidic platforms 
2. Development of a parallelized microvortex array (PMA) system for NP 
manufacturing. 
3. Development of automated experimental microvolumetric sampler for precision 
analysis. 
Page | 15  
 
These goals are multifaceted requiring optimization and minimization of key 
parameters effecting LPNP quality. The single-reactor level needs to be analyzed to 
maximize quality of LPNP prior to parallelization. As with most engineering problems, a 
single solution is rarely unique for a broad range of applications and generalization of the 
process come with a cost. In the case of microfluidic inlet pressure control, the design 
criteria of the system are set as less than 0.5s settling time, zero steady-state error, and less 
than 5% overshoot.   
The microvolumetric sampler device is designed to overcome limitations of human 
variation in both time points and volume of samples. The design criteria of the 
microvolumetric sampler device are set to less than 0.3s settling time, zero steady-state 
error, and less than 2% overshoot. The overall design of the apparatus needs to be 
expandable to allow a multiplicity of samples as various desired volumes to increase the 
versatility and applications of the device. 
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Chapter 2 High-Precision Feedback Pressure Control for 
Microfluidic Systems 
In this chapter, an enhanced nonlinear pressure modulation mechanism model is 
developed based on independent controls of dual fluidic resistances for long-term, high-
speed, and high-precision (less than 0.5% steady-state error) control of the inlet pressure 
in microfluidic devices. Instead of using a single DC motor applied in a previous model 
[106, 107], dual linear actuators are implemented to achieve independent modulation of 
dual fluidic resistances, which provides versatile controller design and implementation. 
Through continuous and discrete time models (SIMULINK®) of the nonlinear pressure 
modulation mechanism, system dynamics are predicted and utilized to tune a linear 
controller for the system. With the tuned controller, system responses on implemented 
hardware are demonstrated to show the performance of the controlled system and address 
long-term stability of this advanced model. 
2.1 Nonlinear Modeling 
The pressure control system (Figure 2.1) consists of two independent variable 
resistances, 𝑢𝑢𝑅𝑅1 and 𝑢𝑢𝑅𝑅2, to control the inlet pressure of a microfluidic device. These 
variable resistances are modulated by the displacement of two independently controlled 
linear actuators, inducing a compression/release of elastic tubing inducing a nonlinear 
change in cross-sectional area. Feedback of the microfluidic inlet pressure regulates the 
linear actuator displacement in response to differences from a desired reference pressure. 
In this pressure modulation mechanism, 𝑢𝑢𝑅𝑅1 is decreased and 𝑢𝑢𝑅𝑅2 is increased for an 
increase in pressure, while 𝑢𝑢𝑅𝑅1 is increased and 𝑢𝑢𝑅𝑅2 is decreased for a decrease in pressure. 
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Figure 2.1 Feedback pressure control schematic 
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To develop a model of the pressure control system, the schematic is decomposed into 
a fluidic circuit analog (Figure 2.2), consisting of fluidic resistance R, fluidic capacitance 
C, and two variable fluidic resistances, 𝑢𝑢𝑅𝑅1 and 𝑢𝑢𝑅𝑅2. Pr represents the reference pressure 
that is applied to the source. Rr represents the fluidic resistance of the connection between 
the source and 𝑢𝑢𝑅𝑅1. P represents the pressure at the inlet of a microfluidic channel, which 
is to be controlled in the model. Ri represents the fluidic resistance of a microfluidic inlet. 
Ro represents the fluidic resistance of a microfluidic outlet. It was previously shown [106] 
that the contribution of Po to the change in P can be neglected if Po << P when the inlet 
resistance Ri is on the order 1E+3 greater than 𝑅𝑅𝑜𝑜. In this model, the total flow q is divided 
into three flow rates (4). 
 𝑞𝑞 = 𝑞𝑞𝑢𝑢𝑅𝑅2 + 𝑞𝑞𝐶𝐶 + 𝑞𝑞𝑅𝑅𝑖𝑖 (4) 
From the fluidic circuit analog, individual flow rates for total flow (5), flow to the 
reservoir, 𝑞𝑞𝑢𝑢𝑅𝑅2  (6), flow due to tubing capacitance, 𝑞𝑞𝐶𝐶 (7), and flow to the microfluidic 
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Figure 2.2 Pressure control system fluidic circuit analog 
By substituting equations (5), (6), (7), and (8) into equation (4), the nonlinear dynamic 
















This equation represents a first-order nonlinear differential equation where the time 
constant can be tuned by modulating the two inputs of the independent resistances 𝑢𝑢𝑅𝑅1 and 
𝑢𝑢𝑅𝑅2. Given that each variable resistance has a lower bound, for a fully released tube, greater 
than 0, the dynamics of the system can be shown to be stable for all combinations of 𝑢𝑢𝑅𝑅1 




𝑅𝑅𝑀𝑀𝑢𝑢𝑅𝑅2 + 𝑅𝑅𝑀𝑀�𝑢𝑢𝑅𝑅1 + 𝑅𝑅𝑟𝑟� + 𝑢𝑢𝑅𝑅2�𝑢𝑢𝑅𝑅1 + 𝑅𝑅𝑟𝑟�
 (10) 
By perturbing the system away from the equilibrium point by 𝜖𝜖, where 𝜖𝜖 ≪ 1, the rate 
of change of the pressure, 𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
, the response of the system can be examined (11). From the 
equation, any perturbation, either positive or negative, drives the system back towards the 
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equilibrium point by resulting in 𝑑𝑑𝑃𝑃/𝑑𝑑𝑑𝑑 opposite in sign to the perturbation, an indication 




±𝜖𝜖 ��𝑅𝑅𝑀𝑀 + 𝑅𝑅𝑟𝑟 + 𝑢𝑢𝑅𝑅1�𝑢𝑢𝑅𝑅2 + 𝑅𝑅𝑀𝑀�𝑢𝑢𝑅𝑅1 + 𝑅𝑅𝑟𝑟��
𝑢𝑢𝑅𝑅2𝐶𝐶𝑅𝑅𝑀𝑀�𝑢𝑢𝑅𝑅1 + 𝑅𝑅𝑟𝑟�
 (11) 
To complete the model, the variable resistance of the tubing needs to be incorporated. 
When the linear actuator deforms (compresses or releases) the connective tubing to modify 
the fluidic resistance, the deformation of the tubing is nonlinear. By assuming a constant 
inner circumference of the tubing through the deformation, the nonlinearity can be 
approximated by using weighted averages of both circular and rectangular cross sections; 
the circular model is accurate near the start of tube compression (i.e., fully released) while 
the rectangular model is relatively accurate near the end of the tube compression (i.e., fully 
compressed). To estimate the deformed cross section area of the tubing, a model for the 
full range of the tubing deformation (Figure 2.3) was developed, through a linear 
combination of the resistance equations based on total displacement. The elastic tubing 
dilatability was not incorporated into the model to maintain simplicity. Additionally, the 
mathematical derivation of an elliptical cross-sectional area is increasing complex with 
time-varying semi-minor and semi-major axis and does not fully define be deformed tubing 
shape due to the linear actuator tip geometry, therefore elliptical approaches were not 
considered. Although an advantage of feedback control is the elimination of the steady-
state error allowing for conservative resistance estimations to achieve similar performance; 
by decreasing the error of the estimation, a more versatile controller can be designed to 
achieve desired performance. 
Page | 21  
 
 
Figure 2.3 Variable Resistance Model 
The mathematical equation for 𝑢𝑢𝑅𝑅1 is modeled as an open tubing (12). Where R 
represents the original radius of the tubing, µ represents the viscosity of the liquid, L 
represents the length of compression, and ℎ(𝑥𝑥1) (13) represents the height of the tubing 
(i.e. the displacement of the linear actuator subtracted from the diameter of the tubing). 
Similarly, the equation for 𝑢𝑢𝑅𝑅2 is modeled as a pinched tubing to reflect the resulting 
asymmetric motion in the pressure modulation mechanism. The equation for 𝑢𝑢𝑅𝑅2  is 
obtained by substituting for 𝑥𝑥1 using the relationship defined in (14), where α is a 
proportional scaling constant. Using these equations, the resistance of the tube can be 
















 ℎ(𝑥𝑥1) = 2𝑅𝑅 − 𝑥𝑥1 (13) 
 𝑥𝑥1 = 2𝑅𝑅 − 𝛼𝛼𝑥𝑥2 (14) 
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2.1.1 Single vs Dual Resistance Model 
To compare the contribution of the additional variable resistance for pressure control, 
the transfer function, between the inlet pressure, P, and the linear actuator displacement, x, 
is first constructed from state-space matrices derived through linearization of the pressure 
dynamic equation (9). These state-space matrices can be represented with state variables 














1� ?̇?𝑥 (15) 
  𝑦𝑦 = [1 0] �𝑃𝑃𝑥𝑥� (16) 
where F represents the equation of motion (9) and 𝑥𝑥𝑜𝑜 represents the equilibrium 
condition (Table 2.1).  By converting the linearized state-space model to an equivalent 
transfer function, through standard equations, and simplifying the resulting equation, the 
pressure dynamic transfer function is a type 0 strictly proper transfer function (17). To 
observe the benefits of a second variable resistor, the examination of actuator dynamics, 
which are congruent across each design, are excluded. 
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Table 2.1 Parameters for Pressure System Equilibrium Point 
PARAMETERS  VALUE UNIT 
𝑥𝑥𝑜𝑜 Equilibrium Actuator Position 3.9E-4 𝑚𝑚 
𝑃𝑃𝑟𝑟 Source Pressure 68.9 𝑘𝑘𝑃𝑃𝑃𝑃 
𝑃𝑃𝑜𝑜 Initial Microchannel Pressure 15.1 𝑘𝑘𝑃𝑃𝑃𝑃 
𝑅𝑅𝑟𝑟 Upstream resistance 1.0E+10 𝑃𝑃𝑃𝑃 𝑠𝑠/𝑚𝑚3 
𝑅𝑅𝑀𝑀 Microchannel Resistance  3.2E+20 𝑃𝑃𝑃𝑃 𝑠𝑠/𝑚𝑚3 
C Microchannel Capacitance 7.6E-12 𝑚𝑚3/𝑃𝑃𝑃𝑃 
𝑢𝑢𝑅𝑅1 Variable Resistance 1 3.4E+9 𝑃𝑃𝑃𝑃 𝑠𝑠/𝑚𝑚3 
𝑢𝑢𝑅𝑅2 Variable Resistance 2 3.7E+9 𝑃𝑃𝑃𝑃 𝑠𝑠/𝑚𝑚3 
𝑑𝑑𝑢𝑢𝑅𝑅1
𝑑𝑑𝑥𝑥
 Derivative of 𝑢𝑢𝑅𝑅1 w.r.t. x 2.5E+13 𝑃𝑃𝑃𝑃 𝑠𝑠/𝑚𝑚4 
𝑑𝑑𝑢𝑢𝑅𝑅2
𝑑𝑑𝑥𝑥




















For a single variable resistor model, all the fluidic drainage flows through the 
microfluidic device (i.e., 𝑞𝑞𝑢𝑢𝑅𝑅2 = 0;𝑢𝑢𝑅𝑅2 = ∞), where the resistance is 10-fold greater than 
elastic tubing. This leads to long transient time (minutes to hours) for the system to reach 
steady-state, which will be examined through comparison of the system time constants. 
The transfer function for the single variable resistance model is simply obtained by letting 
𝑢𝑢𝑅𝑅2 approach infinity (i.e., the outlet is closed) in equation (17). Utilizing this transfer 
function (17) the time constants for the single variable resistance model (SVR; (18)) and 
the dual resistance model (DVR; (19)) can be computed. 










𝑢𝑢𝑅𝑅2�𝑅𝑅𝑟𝑟 + 𝑢𝑢𝑅𝑅1� + 𝑅𝑅𝑀𝑀𝑢𝑢𝑅𝑅2 + 𝑅𝑅𝑀𝑀�𝑅𝑅𝑟𝑟 + 𝑢𝑢𝑅𝑅1�
 (19) 
From these time constant definitions, it can be shown that as 𝑢𝑢𝑅𝑅2 approaches infinity 
(i.e. the outlet is closed) the dual variable resistance time constant (19) converges to the 
single variable resistance time constant (18). To show the increase in performance of the 
dual resistance model,  the condition of 𝜏𝜏𝐷𝐷𝑆𝑆𝑅𝑅 < 𝜏𝜏𝑆𝑆𝑆𝑆𝑅𝑅  reduces to a simple inequality (20). 
Given that each of the values is strictly greater than 0, the inclusion of 𝑢𝑢𝑅𝑅2 always results 
in a faster system response and remains true for all values of 𝑢𝑢𝑅𝑅1. 
 𝑅𝑅𝑀𝑀�𝑅𝑅𝑟𝑟 + 𝑢𝑢𝑅𝑅1� > 0 (20) 
2.2 Nonlinear Simulation and PI Controller Design 
The equation of motion of the nonlinear system (9) was developed into a nonlinear 
continuous time model using SIMULINK®, which consists of a single feedback loop 
controlled indicative of a pressure sensor (Figure 2.4). The Linear Actuator Block converts 
the controller output into a linear actuator displacement. This displacement is regulated by 
applying constraints to the rate of change (i.e., the velocity of the motor) and the position 
of the linear actuator ensure that the elastic tubing remains in contact with the actuator. 
Violation of the latter constraint will lead to negative resistances within the actuator 
resistance model (12). The velocity of actuator was defined to be consistent with the 
physical model, at 7mm/s. The Variable Resistor Dynamics Block converts the constrained 
linear actuator displacement into the variable resistance values which are utilized by the 
Pressure Dynamics block to implement the equation of motion (9). The static gain 
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represented in the system converts the standard international units of Pascals (Pa) to the 
pounds per square inch (psi) represented by the pressure sensor voltage conversion in the 
physical system. This allows the designed simulated controller to be more directly 
implemented on the physical hardware. A continuous model was developed rather than a 
discrete model, representative of all physical systems, because of the 1kHz sampling rate 
of the pressure sensor. Both models are compared after the implementation of a design 
controller. 
 
Figure 2.4 Nonlinear Pressure Control Simulink Model 
A proportional-integrative (PI) controller was developed for the system, to eliminate 
the steady-state error for a step input, by minimizing the error between the reference 
pressure and current pressure value. The PI controller was ad hoc tuned to achieved rise 
time less than 0.3 seconds while maintaining percent overshoot less than 2%, yielding gains 
of 3000 and 60000 for 𝐾𝐾𝑝𝑝 and 𝐾𝐾𝑀𝑀, respectively. Other controller tuning approaches (i.e., 
Ziegler-Nichols) were implemented but could not satisfy the specified design criteria. The 
control effort is applied, after the completion of the loop, to the linear actuator dynamics 
to calculate the variable resistances for pressure modulation.  
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To compare the continuous model to a discrete model, a reference pressure set to 
decrease from 25.1 kPa to 5.1 kPa at 0.5 s; and a pressure increase from 5.1 kPa to 25.1 
kPa at 1 s was generated. The response of the continuous system maintains overshoot less 
than 1.5%, a settling time less than 0.1 s and zero steady-state error, satisfying the design 
requirements. The similarity between the discrete and the continuous responses (Figure 
2.5) can be attributed to the high sampling rate of the pressure sensor in the discrete time 
model, 1 kHz, allowing for the reconstruction of the continuous time model.  
 
Figure 2.5 Discrete versus Continuous Simulation 
The implementation of the designed PI controller on the physical system had to be 
modified to achieve desired performance due to the higher complexity of the physical 
system dynamics not represented in the modeling. This complexity includes the differences 
between the approximated tube resistance and true resistance, the incorporation of tubing 
elasticity and dilatability, and noise and/or accuracy error associated with the pressure 
sensor.  
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2.3 Experimental System Performance 
 
Figure 2.6 Computer Schematic of Pressure Control System 
The system was designed with commercially available electronic components: 
• Linear actuator, LAC10A-T4-MC04 (Zaber Technologies, Inc., Vancouver, BC, 
Canada); 
• Stepper Motor Controller, A-MCA-KT05 (Zaber Technologies, Inc., Vancouver, BC, 
Canada); 
• 16-bit AD/DA converter CardBus CSI-360116 (Interface Amita Solutions, Inc., 
Campbell, CA); 
• pressure sensors (ASDX series, Honeywell International Inc., NJ); 
• USB-COM232-Plus4 (Future Technology Devices International Ltd, United Kingdom) 
These components were connected to a laptop computer via a CardBus port, allowing 
for real-time monitoring of inlet pressure. The control software coded by C language was 
developed and implemented to the laptop computer. The software was composed of two 
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different timer threads; the one for a designed PI controller (sensing and control thread) 
with 1 ms cycle and the other with 30 ms cycle GUI thread for data drawing and interactive 
parameter tuning (Figure 2.6). A 60Hz filter was implemented in the coding architecture 
to reduce electrical noise associated with the pressure sensor, increasing overall accuracy. 
 
Figure 2.7 Experimental Region of Interest 
To evaluate the performance of the controlled system, the responses to both step and 
sinusoidal inputs were experimentally evaluated at varying degrees of pressure drops and 
varying frequencies, respectively, to determine the extent of performance. In these 
examinations, the response was analyzed from the initiation of reference signal, neglecting 
the initialization of the linear actuators (i.e., both fully pinched tubes; Figure 2.7). 
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Figure 2.8 Experimental Evaluation of Pressure Drops 
Step responses of pressure drops showed settling times less than 0.3 seconds with zero 
steady-state error (Figure 2.8), where pressure drops of (A) 24, (B) 16, and (C) 8kPa are 
examined. The speed of the decrease is a function of the tube diameter of the reservoir, a 
direct correlation to the fluidic drainage. By allowing a larger diameter tubing, more fluidic 
drainage can occur leading to sharper decrease in pressure. Although a maximum pressure 
drop of 24kPa was demonstrated, by increasing reservoir tube diameter and applying a 
well-tuned controller, comparable results can be obtained for larger pressure ranges. A 
consideration of a larger reservoir is the linear actuator velocity, effecting the volumetic 
rate of change and pressure modulation.  
The profile of the experimental results matches the simulated results (Figure 2.5); 
however, the settling time of the simulated results remains faster, at less than 0.1 seconds. 
This discrepancy between experimentation and simulations can be a function of the 
unmodeled nonlinearities of the physical system and the change of fluidic inertia. The 
fluctuation in the steady-state values in these step responses is attributed to factors 
including external disturbances (e.g. air bubbles in the tubing); rippling of tubing due to 
high elasticity; and linear actuator perturbations. In addition, the pressure sensor has a 12-
bit resolution that may restrict the measurable accuracy. These in combination are 
attributed to the absolute error at steady-state. 
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Figure 2.9 Experimental Evaluation of Sinusoidal Pressure Curves 
Sinusoidal responses of the pressure control system were observed at (A) 1, (B) 4 and 
(C) 8 Hz (Figure 2.9). It was observed that as the frequency increases (≥ 8 Hz), limited 
performance in reference following occurs (i.e., a phase lag and/or a lowered amplitude). 
Each response can be shown, through the Fast Fourier transform, to match the reference 
sinusoidal frequency at steady-state. There is a decrease in amplitude, beyond 6 Hz, which 
can be partially attenuated by increasing the proportional gain; however, remains limited 
at higher frequencies (>8 Hz). This limitation results from the limited speed at which the 
linear actuators can change the resistance and transient response of the fluid to a change in 
pressure differential. Asymmetric sinusoidal and beat signals can be performed with 
matching amplitude if the maximum frequency remains below 6Hz.  The phase lag of the 
system is attributed to the controller architecture developed. By using a simple PI controller 
for the system, the error of an oscillating signal cannot be driven to zero. To overcome this 
limitation, implementation of a zero-phase error tracking control (ZPETC) approaches 
[121] or more simply by measuring the phase lag, the input signal can be delayed 
appropriately through command shaping to eliminate the phase lag. 
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2.3.1 Pressure System Comparison 
A previously developed variable resistance-variable reservoir model for the control of 
the inlet pressure of the microfluidic device [106] was found to contain a mechanical 
constraint, limiting performance of the system.. The variable reservoir provided an 
alternative fluidic drainage path for rapid decreases in pressure.  To observe differences in 
performance between the dual resistance model and variable resistance-variable reservoir 
model, the mechanically linked operation for adjusting the variable resistor and variable 
reservoir was replaced with the two independent linear actuators. Consistent with the dual 
resistance model, an increase in pressure is facilitated by a decrease the variable resistance, 
and a compression of the variable reservoir. This compression in turn contributed to an 
increase in pressure, resulting in an overestimated overshoot of the controlled pressure. 
Similarly, when the pressure is decreased an undershoot was obtained. Due to this 
mechanical constraint of the variable resistance-variable reservoir model, a fluctuation 
developed (Figure 1.2) within 2 min.  
To minimize this fluctuation, the variable resistance-variable reservoir model 
maintains the pressure by either decreasing resistance to the pressure source or by 
decreasing the volume of the variable reservoir. Particularly, the time derivative of 
volumetric change in the variable reservoir was observed as the primary contributor for 
high-speed pressure regulation. Once the reservoir is fully compressed by the linear 
actuator, the pressure can no longer be increased. This causes the pressure to decay until 
the system responds by decreasing the variable resistance, causing a sharp increase in 
pressure. This pattern is repeated until the system stabilizes within a percent error of the 
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desired reference signal. Here a PI controller was tuned to achieve an error at stabilization 
within 2.5%, with a root-mean square of the error of 1.361. 
By replacing the variable reservoir with a constant outlet, controlled by 𝑢𝑢𝑅𝑅2, the dual 
resistance model eliminates the pressure modulation facilitated by the fluidic drainage 
mechanism. This reduces the overshoot and undershoot observed in the variable resistance-
variable reservoir model and eliminates fluctuation during long-term experimentation 
(Figure 2.10).  By examining the absolute steady-state error, an overall reduction of error 
below 0.5%, with a root-mean square of the error of 0.030 is observed. The oscillatory 
behavior observed in the variable reservoir model within two minutes does not arise in the 
dual resistance model, even after 3 hours of operation. The use of a second variable 
resistance has consideration with respect to the waste of precursor solution. Because the 
system is open, the fluid drains out of the system into a collection reservoir, providing 
reusable material. For long-term experimentation, control of the waste production, related 
to the controller design, is an important constraint. Within the experiments presented here, 
the waste was negligible with the controller designed.  
 
Figure 2.10 Long-Term Pressure System Response 
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2.4 Conclusions 
A long-term, high-speed, and high precision (less than 0.5% steady-state error) system 
was developed control of microfluidic pressure using the advanced pressure modulation 
mechanism (the dual resistance model). The nonlinear models were simulated to validate 
the use of a 1 kHz sampling rate with no signal loss. A continuous time model simulation 
was performed to show the performance of a linear controller for the nonlinear model. A 
tuned PI controller was developed, enabling the physical system to have a step response 
reaching the steady-state within 0.3 s within 0.5% steady-state error. Using the dual 
resistance model, the steady-state fluctuations that were caused by the previous variable 
resistance-variable reservoir system [106] were eliminated. This high-precision, high-
speed control for long-term experimentation in microfluidic systems can be applied to 
controlled manufacturing of nanomaterials, which remains a current challenge of syringe-
pump based systems. The dual resistance model system can be utilized in a variety of areas 
including biological instrumentation [47, 122], organ on a chip [123], chemical gradient 
manipulation (e.g. controlled drug delivery over a tissue) [124], and chemical synthesis 
(e.g. nanoparticle synthesis) [25, 125]. This work explores the integration of the pressure 
control system with NP synthesis and large-scale manufacturing to maintain quality control 
to be addressed in Chapter 3.  
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Chapter 3 Parallelized Microfluidics for Robust 
Nanomanufacturing 
In this chapter, a parallelized array of microfluidic devices is developed through the 
process of optimizing the single-reactor synthesis, determining critical parameters for 
synthesis, and developing models to predict mixing efficiencies of precursor solutions. 
From the modeling, the parallelized array is refined and optimized to ensure reaction 
consistency. The device is prototyped with PDMS and further refined prior to final device 
fabrication. With the feedback pressure control system developed in Chapter 2, the 
parallelized microvortex array (PMA) is coupled with control theory for robust 
nanomanufacturing. Lipid-polymer nanoparticles (LPNPs), engineered high-density 
lipoproteins (eHNP), liposomes (LNPs), and polymeric NPs (PNPs) are explored on the 
swirling microvortex reactor (SMR) for large-scale manufacturing validation. The process 
developed within this chapter can further be extrapolated to other microfluidic platforms 
by following the process described here. 
3.1 Swirling Microvortex Reactor 
To develop a large-scale parallelized array, the individual SMR needs to be developed 
and optimized by assessing the critical parameters to NP synthesis. The SMR was initially 
developed as the single-reactor unit by modeling and tuning the reactor mixing efficiency, 
a predictive measure of reaction conditions empirically linked to NP size uniformity. 
Computational fluid dynamics (CFD) simulations to achieve a 90% or higher mixing 
efficiency with varied SMR diameters (Figure 3.1). The mixing efficiency is a linear 
scaling of the mass fraction of precursor solutions (Figure 3.2), weighting a 50:50 mass 
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fraction as the ideal mixing of the precursors, given by equation (21). Using the mixing 
efficiency metric allows for comparison of not just individual SMR reactor designs but will 
be used to assess the PMA reactor consistency and comparison to the SMR. 
 𝑀𝑀𝑀𝑀𝑥𝑥𝑒𝑒𝐷𝐷𝐷𝐷 = �
2𝑀𝑀𝐷𝐷𝑟𝑟𝑓𝑓𝑐𝑐𝑑𝑑, 𝑀𝑀𝐷𝐷𝑟𝑟𝑓𝑓𝑐𝑐𝑑𝑑 < 0.5
2(1 −𝑀𝑀𝐷𝐷𝑟𝑟𝑓𝑓𝑐𝑐𝑑𝑑), 𝑀𝑀𝐷𝐷𝑟𝑟𝑓𝑓𝑐𝑐𝑑𝑑 ≥ 0.5
 (21) 
 
Figure 3.1 SMR Development 
 
Figure 3.2 Mixing Efficiency Standard 
The mixing efficiency of SMRs with diameters of 1mm, 2mm, and 4mm have 
characteristic mixing times (4ms, 16ms, and 64ms, respectively) less than the residence 
time (20ms, 40ms, and 80ms, respectively) of the reactor when the height is held constant 
Page | 36  
 
at 5mm. The larger the reactor, the larger the characteristic mixing (𝜏𝜏𝑚𝑚𝑀𝑀𝑀𝑀) and residence 
times (𝜏𝜏𝑟𝑟𝑒𝑒𝑠𝑠) become.  Specifically, the characteristic mixing time remains lower than the 
residence time while the hydraulic diameter, the SMR outlet diameter, is less than the 
height of the reactor. Larger reactors have greater LPNP production rate, due to higher flow 
rate, but decrease the number of reactors per unit area; conversely, smaller reactors 
decrease LPNP production and increase the multiplicity of reactors per unit area. Governed 
by equations (22)-(23), where 𝐷𝐷ℎ represents the hydraulic diameter of the reactor, 𝑣𝑣 
represents the fluid velocity, 𝑉𝑉 represents the total reaction volume, and 𝑄𝑄 represents the 
total flow rate. 








With the tuned SMR, highly reproducible LPNPs are continuously produced with high 
size uniformity at a rate of 3g/h (Figure 3.3), based on inlet flow rates and concentrations 
with 100% yield. LPNPs combine the unique strengths of LNPs and PNPs while 
overcoming their limitations in terms of drug encapsulation efficiency and storage stability 
[63, 64], respectively. The simulations were experimentally validated by synthesizing 
LPNPs in the SMRs with various diameters (1mm, 2mm, and 4mm) at a constant Re of 
250 (Figure 3.4A), a transitional boundary above which swirling vortex flow patterns 
become chaotic.  
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Figure 3.3 SMR LPNP Production Schematic 
The 2mm diameter, where computationally, the highest mixing efficiency (0.92, 
volumetric average in a SMR) was obtained; demonstrated the narrowest LPNP size 
distribution (Figure 3.4A) in the experimental synthesis validation. The size distribution 
and NP quality were demonstrated to have fine control with respect to the precursor 
composition (Figure 3.4B) and the ability to control the size simply by varying flow rates 
(i.e., Reynolds numbers; Re) without changing the precursor composition (Figure 3.4C). 
Increasing the Re into the chaotic regime above 250 doesn’t cause a further decrease in the 
NP size or quality, indicating a physiological limit of LPNP on the SMR platform. For 
large scale parallelization, the minimization of precursor composition variation is more 
critical than minimization of Re variations because of the high operating Re of 250. 
 
Figure 3.4 SMR Experimental Nanoparticle Synthesis Validation  
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3.1.1 Pressure Control Integration and Analysis 
To produce NPs with high reproducibility, the SMR was integrated with the custom 
high-precision, feedback pressure control system detailed in Chapter 2. To calculate the 
synthesis conditions, first the SMR was decomposed into equivalent resistances and 
constructed a fluidic circuit analog of the coupled system with both inlets (Figure 3.5). 
Coupled with the equation for Re [79, 126], the SMR inlet pressure is given as below (24). 
 












𝑤𝑤ℎ3 �1 − 0.63 ℎ𝑤𝑤�
 (26) 
where 𝜇𝜇 represents the dynamic viscosity, 𝜇𝜇 represents the cross-sectional area of the 
SMR, 𝜌𝜌 represents the fluid density, 𝐷𝐷𝐻𝐻 represents the hydraulic diameter, and 𝑅𝑅𝑅𝑅 
represents the Reynolds number. The definitions of the 𝑅𝑅1 and 𝑅𝑅2 are given by the 
respective square (26) and circular (25) resistances. This equation (24) is used to calculate 
the pressure range corresponding to the Re designed in this study (Figure 3.6A). As 
previously discussed, the control system demonstrated the performance with less than a 0.3 
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second settling time is maintained across the various Re (Figure 3.6B). The performance 
of the pressure control system (PC) was compared with a commercially available syringe 
pump (SP); demonstrating a 50 times faster transient response (Figure 3.6C) and more 
stable in long-term regulation of a flow rate (Figure 3.6D). Both the transient and steady-
state response of the PC demonstrate more robustness than the SP, impacting the flow rates 
for NP synthesis and, ultimately, NP quality.  
 
Figure 3.6 SMR Feedback Controller Performance 
With this superior performance of the high-precision control system, the size 
uniformity of NPs synthesized on the SMR were assessed by comparing the size 
distributions and the polydispersity index (PDI), a measure of the homogeneity of the size 
distributions. LPNPs produced on the SMR using the developed feedback pressure control 
system demonstrated narrower size distributions than those using a syringe pump for 
steady-state (long-term) (Figure 3.7A and B) and transient (short-term) performance 
Page | 40  
 
(Figure 3.7C and D). The transient response includes the prefilled channel where mixing 
conditions are not ideal; leading to higher PDI, especially for systems exhibiting long 
transient flow responses (e.g., syringe pumps). The steady-state response is taken after the 
ideal mixing conditions are achieved  
 
Figure 3.7 Steady-state/Transient Nanoparticle Synthesis Comparison 
The difference in the NP distributions and PDI values from the steady-state response 
is because feedback pressure control system rejects external disturbances and minimizes 
the variation in the inlet pressure of the SMR (Figure 3.7A and B). This disturbance 
rejection preserves the Reynolds number and precursor composition, which are two critical 
factors that affect NP physicochemical properties. The difference in the NP distributions 
from the transient response is because it takes longer (settling time upwards of minutes) 
[92, 93] for the syringe pump to reach steady-state values than for the feedback pressure 
control system (less than 0.3 second settling time response) (Figure 3.7C and D).  
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3.1.2 Nanoparticle Versatility 
Although LPNPs have a broad range of applications, research for engineered high-
density lipoproteins (eHNPs), liposomes (LNPs) and polymeric NPs (PNPs) remains 
active. Each of these particle types have been developed into nanotherapeutics for a 
treatment of an enormous range of diseases. Repeatable synthesis and narrow size 
distributions are essential to such applications. Therefore, to explore the versatility of the 
SMR, each of these nanoparticle formulations were examined. 
High-density lipoprotein (HDL) is a rapidly expanding area of research [4, 127-130] 
because of ability to incorporate therapeutics and cross the blood-brain barrier. This 
synthetic HDL are referred to as engineered high-density lipoprotein (eHNP). Composed 
of apolipoprotein A1 band around a lipid disk, nascent eHNP is commonly responsible for 
the removal of cholesterol from the body by removing cholesterol, promoting overall 
health.  Both computationally [131] and experimentally [130], discoidal eHNP was found 
to be around 10 nm is size. Discoidal eHNP synthesized on the SMR (Figure 3.8) was 
consistent with current research. Further study needs to include the incorporation of 
cholesterol, changing the morphology to spherical particles, and therapeutic agents. 
Additionally, there are several types of apolipoprotein that can modify the chemistry and 
reactivity of eHNP for new nanotherapeutics. 
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Figure 3.8 SMR Synthesized eHNP 
Polymeric nanoparticles (PNPs; Figure 3.9A) have been used and developed because 
of their high drug loading capacity and ease of synthesis. Requiring the reaction of 
PEGylated PLGA with water, PNPs have been commonly synthesized with diffusion-
based microfluidics [19, 83] with more recent approaches demonstrating turbulent 
impinging mixing [32] with an average particle size of approximately 33 nm. Synthesizing 
PNPs on the SMR at various concentrations (Figure 3.9B) yields interesting results, 
whereas the concentration or the precursor solution is increased the size of the particle 
decreases. This can potentially be the result of the increase in concentration decreasing the 
distance between molecules, allowing for more rapid synthesis of stable particles. This is 
coupled with the particle-particle interactions that may prohibit the formation of larger 
particles. Each of the cases additionally has a proceeding tail of large PNPs due to the 
reaction. This may be related to the use of a 50:50 ratio of water and acetonitrile (organic 
solvent for PLGA-PEG). The previous diffusive and turbulent approaches only used a 5% 
acetonitrile concentration in the finalized product [19, 83]. To examine the effect of the 
acetonitrile (ACN) concentration, the 15 mg/mL case was examined with the 50% ACN of 
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normal synthesis (i.e., Re 250 with equal precursor flow conditions), 25% ACN by 
prefilling the collection vial with water with normal synthesis, and 10% ACN by creating 
asymmetric flow conditions (Figure 3.9C). The hypothesis of the increase in the ACN is 
that ACN can potentially cause particles to disassociate leading the larger aggregations. 
The observation shows that when smaller percentages of ACN are used there is a decrease 
in the tail size. Interestingly, the water prefilled approach lead to the smallest decrease in 
the PNP tail and peak size (19nm). The reaction needs to be further refined based on these 
results to minimize the trailing edge of the size distribution, an indication of a polydisperse 
mixture.  
 
Figure 3.9 SMR Synthesized PNP 
Lastly, liposomes (LNP; Figure 3.10A) have been developed as nanotherapeutics 
because of their biocompatibility [54, 55, 132], easily tunable surface chemistry, and 
natural occurrence in vivo. Comprised of a lipid-bilayer, LNPs can be formed by reaction 
a solution of lipids, in ethanol, and a solution of water. The complexity of the reaction is 
that there is a potential biproduct of micelle formation, a single layer particle with a 
hydrophobic core. As the concentration of the lipid (DPPC) is reduced size of the particle 
is reduced (Figure 3.10B). The large size of the particles indicates the aggregation of 
lipids/particles at higher concentrations, forming macroparticles. The 0.25 mg/mL 
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concentration yields a small size of 100 nm particles; however, the mixture is very 
polydisperse. The refinement is multifaceted, as a function of both the initial lipid 
concentration and the final synthesized ethanol concentration. Since the reaction is 
dependent on solvent inversion, having a 50% solution of ethanol, like the PNP case, can 
result in the dissolution of formed LNPs and possibly lead to aggregation during the 
filtration process.  To examine the effect of the ethanol (EtOH) concentration, the 1 mg/mL 
case was examined with the 50% EtOH of normal synthesis (i.e., Re 250 with equal 
precursor flow conditions), 25% EtOH by prefilling the collection vial with water with 
normal synthesis, and 10% EtOH by creating asymmetric flow conditions (Figure 3.10C). 
The results demonstrate that as the percent solvent is decreased, the size of the LNP is 
decreased as well. The lowest case (10% EtOH) is consistent with previously reported 
literature [133]. The lipid solution does not contain pegylated lipid, as in the synthesized 
LPNP, which can help to stabilize the particle and potentially prevent this aggregation. The 
optimization of the reaction needs to be looked at from multiple viewpoints to discern 
process by which LNPs form on the SMR.  
 
Figure 3.10 SMR Synthesized LNP 
Each of these alternative NP formations needs to be further refined and modified to be 
utilized as a nanotherapeutic, but with the distributions and discussion, the potential of 
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these platforms on the SMR device has been shown. The single component synthesis with 
PNPs and LNPs needs to further be explored as it is no longer dependent on a ratio of 
precursors but rather the mixing conditions, related to the Re, the solvent concentration, 
and precursor composition. The optimization of these syntheses will need to be further 
studied to better understand and refine the NPs. In addition to refining the synthesis of the 
individual formulations, the incorporation of drugs (e.g., doxorubicin) needs to be 
evaluated on the SMR for nanotherapeutic development. The demonstration of the NP 
formulations on the single-reactor can be extended through the parallelization of the SMR 
for nanomanufacturing.  
3.2 Parallelized Microvortex Array 
To develop the large scale parallelized microvortex array (PMA) of SMRs, it is critical 
to maintain reaction consistency to ensure a uniform and narrow size distribution across all 
SMRs. In the development of the SMR, both the Re and the mass fraction of the precursor 
solutions were found to be the two parameters affecting the size distribution (Figure 3.4). 
From these two variables, the minimization of the precursor composition is most critical to 
reactor consistency because small variations resulted in a size shift up to 10nm (Figure 
3.4B). The variation of the Re is less critical for parallelization as the system operates at 
the physiological limit (Re of 250) where small variations minimally affect the size 
distributions (Figure 3.4C). For the modeling and development of the PMA, both variables 
will be minimized to achieve high-precision nanomanufacturing.  
3.2.1 Fluidic Circuit Analog Modeling 
To develop the PMA, a network of microfluidic channels needs to be constructed 
connecting a multiplicity of SMR with common precursor inlets and a common outlet 
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(Figure 3.11A). The dimensions of the channels need to be determined based on equations 
(23-25), to minimize the pressure differentials between each SMR based on channel 
impedances. Similar to determining the pressure differential of the SMR integrated with 
the PC, the microfluidic network is decomposed into an equivalent electrical system.  
 
Figure 3.11 PMA Fluidic Circuit Analog Decomposition 
A fluidic circuit analog [88] to optimize the PMA inlet fluidic impedances (Z1 and Z2) 
given the SMR inlet impedances (Z3 and Z4) (Figure 3.11B) was developed. Each fluidic 
impedance consists of the fluidic resistance, R, and capacitance, C. To minimize pressure 
variations at the inlet of each SMR in the PMA, the microfluidic channels networking the 
SMRs should lead to an identical pressure drop between the pressure source and the inlet 
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of each SMR. This methodology is accomplished by equating the Hagan-Poiseuille 
equation for fluidic systems with Ohm’s Law for electrical circuits, assuming an 
incompressible Newtonian fluid in laminar flow. Within the microfluidic channel hierarchy 
(Figure 3.11B), the Z2:Z3 ratio was found to be a key design parameter to be tuned to 
minimize pressure variations at the inlet of each SMR in the PMA. The ratio is indicative 
of a smaller Z2 resistance represented by a larger channel. The lower the resistance leads 
to a smaller pressure drop between each SMR, governed by the Hagan-Poiseuille equation.  
To determine a desired Z2:Z3 ratio, the flow rate ratio (27) between the inlets of the first 
and Nth SMR within a PMA column and found that an increase in the array size (i.e., the 
number of the tuned SMR in a PMA) requires a decrease in Z2:Z3 ratio to maintain the 
same flow rate ratio. The flow rate ratio assumes that Z4 is much less than either Z2 or Z3, 
which is the case for this system. Ideally, the flow rate ration between the first and Nth 
reactor should be 1. More importantly, the flow rate ratio in a larger array size is more 
sensitive to the variations in the Z2:Z3 impedance ratio, requiring a higher accuracy for 
fabrication in a larger PMA, generally increasing production costs (Figure 3.12). In the 
current platform of 5x5 array, a flow rate ratio (0.92) was utilized resulting in a Z2:Z3 ratio 
(0.021). This mathematical approach allows for the extension to a NxN array, allowing for 
researchers to tune the multiplicity of scaling for various applications. 
 






(𝑁𝑁 − 1) + 1�
−1
 (27) 
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Figure 3.12 Array Size Sensitivity on Design Criteria  
The calculation of the flow rate ratio (27), allows for the optimization of the Z2:Z3 
ratio through iterative coding process. By setting the height of the array to 200µm, the 
height of the SMR inlets, defining the parameters of Z1, and the width of Z2 (3.5mm), the 
coding algorithm can find the design criteria for the system to achieve a desired flow rate 
ratio. Additionally, the overall size of the device (Figure 3.13), a critical constraint for 
manufacturing, can be approximated from the rectangular channel design, assumed in the 
electrical model (Figure 3.14A).  
 
Figure 3.13 Reactors per Array Size 
The area analysis demonstrates that the system reaches a horizontal asymptote, where 
the reactors per 1m2 achieves approximately 1000 reactors. The multiplicity of the PMA 
design, can increase the reactors of the system, reducing overall number of reactors per 
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area, or place a large number of small NxN reactors in parallel, requiring the additional 
control system for proper synthesis. Coupled with the increased fabrication costs of higher 
dimensional arrays, a cost analysis of the overall system can be assessed to optimize the 
design for manufacturers.  
3.2.2 Design Optimization 
The use of a fluidic circuit analog provides the general dimensions; however, the rigid 
nature of the design does not incorporate the complexity of fluid dynamics, in particular 
the Naiver-Stokes equations. To further analyze and optimize the PMA design, CFD 
simulations were used to further tune the electrical PMA model by minimizing local flow 
variations across the initial (Figure 3.14A) and tuned fluidic (Figure 3.14B) models, 
finalizing the PMA design with less than 1% precursor composition variation and less than 
4% Re variation (Figure 3.14C). The optimization of the PMA design increased the 
pressure differential required for ideal synthesis, caused by an increase in the resistance, 
and created a more uniform pressure distribution for each inlet. Due to the increase in the 
resistance of the PMA, the required inlet pressure for the device is increased, requiring a 
modification to the feedback pressure control system with a larger range sensor and 
controller tuning. 
 
Figure 3.14 PMA Computational Fluid Dynamic Simulations 
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This refinement of the PMA model simulated with the ideal PLGA-to-lipid weight 
ratio of 5 and the ideal Re of 250 decreased the variation of the precursor composition at 
the inlet of each SMR in the PMA by 79.4% (Figure 3.15A) and improved the mixing 
consistency across the SMRs by 1.5% (Figure 3.15B) and across the height of the SMR 
(Figure 3.15C). While the average mixing efficiency in the outlet of the PMA (91%) was 
lower than that of the tuned SMR (98%) (Figure 3.1), the difference was not significant as 
a mixing efficiency above 90% showed comparable NP size distribution in the 
experimental data (Figure 3.4A-C). 
 
Figure 3.15 PMA Modeling Analysis 
3.2.3 Prototyping and Fabrication 
To implement the design of the PMA and validate the model, a prototype was initially 
developed utilizing the common photolithography techniques for microfluidics in 
combination with machined molds (Figure 3.16), consisting of 3 distinct layers: 1. 
Parallelized microfluidic array network, 2. Microfluidic reactor pillars, and 3. Collecting 
reservoir.  Initially the prototype was modeled after the electrical fluid analog (Figure 
3.14A) where each of the channels are rectangular with a set height of 200µm. The initial 
prototype was found to be inadequate for the device because the large surface area of the 
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Z1 channels collapsed and bound to the lower substrate (i.e., layer 2 bounded to layer 1), 
disrupting the carefully designed channel dimensions and ultimately modifying the fluid 
dynamics. Additionally, the sharp corners of the device were found to entrap bubbles, 
disrupting the dynamics of the system. 
 
Figure 3.16 Polydimethylsiloxane PMA Prototype Schematic 
The material selection for rapid prototyping for microfluidics is generally 
polydimethylsiloxane (PDMS). Using this material for the with the PMA systems 
presented numerous issues needing to be addressed for proper functionality. During 
synthesis, the PDMS experienced large nonlinear deformation under the large pressure 
differential applied to generate the Re 250 flows. The deformation disrupts the designed 
microfluidic channels causing large Re and precursor variation across all the channels. This 
deformation was caused by the low Young’s Modulus of a PDMS-PDMS bond [30]. 
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PDMS is incompatible with organic solvents for long durations, and the porosity of the 
materials allows for material absorption over time. The inlet connection with microfluidics 
often use compression fitting by sticking either a polyethylene tube or metal needle into a 
punched PDMS hole. The high pressure required for the use of the system dislodges the 
tubing, causing a device failure and potentially exposing researcher to hazardous chemicals 
(e.g., acetonitrile). Each of these issues decreases the longevity and versatility of the 
design, requiring modification to overcome the limitations. 
3.2.4 Robust Nanomanufacturing with Feedback Control 
 
Figure 3.17 Robust PMA Design 
Improving the design of the PMA, the PDMS was replaced with a more robust 304 
stainless steel construction, overcoming both the material incompatibility and the nonlinear 
deformation found in the PDMS model. Due to the use of stainless steel, the device could 
no longer be plasma bonded to eliminate leakages and reactor-reactor contamination. 
Inserted between each of the layers was two ethylene propylene diene monomer (M-class) 
rubber (EPDM) gaskets, compatible with organic solvents (e.g., acetonitrile). To prevent 
leakages of the system, 8 radially spaced bolts were equally compressed with 25lb-in of 
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torque. Lastly, to prevent failure of the device, through tubing disconnection, high pressure 
push-to-connect fittings were integrated into the design for both inlets and the outlet. 
Combining all the modifications, the device is compatible with a variety of solvents, 
doesn’t deform under the required pressure differential, and is easily separable for cleaning 
surfaces between reactions, if necessary. 
To minimize the SMR-to-SMR variation of critical reaction parameters, the inlet flow 
for each precursor is regulated by the feedback pressure control system (Figure 3.18), 
discussed in Chapter 2, to mitigate inlet flow variations in the PMA, a factor that amplifies 
designed parameter variations (i.e., Re and precursor composition).  
 
Figure 3.18 Feedback Control PMA Integration 
By coupling the PMA with the high-precision, feedback pressure control system to 
regulate the inlet pressure of the PMA external disturbances are mitigated, and precursor 
flow fluctuations are reduced. To demonstrate the advantage of coupling the feedback 
control system, production of LPNPs with and without the control in response to an 
external disturbance are compared (Figure 3.19). Without the mitigation of flow 
Page | 54  
 
fluctuations, generated by external disturbances, the NP size uniformity is substantially 
reduced. The integration of the PMA with the feedback control provides not only highly 
reproducible uniform LPNP production for long-term duration but also mitigates external 
disturbances that would otherwise cause a failure to achieve robust manufacturing.   
 
Figure 3.19 Controlled LPNP Synthesis on PMA 
Comparing the distribution of the PMA to the single SMR (Figure 3.20), the 
distributions of both systems are comparable. Compared to bulk mixing process [25, 29], 
the polydispersity of the PMA distribution remains lower than that of conventional bulk 
mixing while achieving a continuous synthesis process. Providing a means to accelerate 
the clinical translation of nanotherapeutics with higher reproducibility, the PMA has a 
robust design for a broad range of applications with the design of the system allowing for 
modification.   
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Figure 3.20 LPNP Synthesis Comparison of SMR vs PMA 
3.3 Conclusions 
A representative example for robust manufacturing (1.8kg/d) of multicomponent NPs 
through feedback controlled, parallelized microfluidic reactors has been presented. The 
unique design of a microfluidic reactor was developed into a parallelized array for large-
scale production of NPs while maintaining the mixing time scales of the single reactor and 
the physicochemical properties (e.g. size) of produced NPs. The impedance ratio of a 
microfluidic channel network linking individual reactors to impedance of individual 
reactor inlet was found to be a key design parameter to be minimized, ensuring reaction 
consistency in a parallelized platform. The microfluidic parallelization approach 
demonstrated that LPNPs could be manufactured without losing the physicochemical 
properties (i.e., size), and the production process could be within a manufacturing quality 
with feedback control. The parallelized reactor design can be further extended to a larger 
array, achieving a greater production rate that addresses the current manufacturing 
challenges that pharmaceutical and biomedical industries face. The integration of advanced 
microfluidic technology with control systems engineering may validate a new impactful 
method for robust NP manufacturing and contribute to efficient development and 
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optimization of a wide range of multicomponent NPs for therapeutic and diagnostic 
applications. 
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Chapter 4 High-Precision Feedback-Controlled Fluidic Sampling 
In this chapter, a tunable low-cost high-precision feedback-controlled sampling 
apparatus to automatically sample specified volumes and times is developed. The design 
of the rotational feedback controller is first modeled and experimentally validated with 
settling times less than 0.3 seconds, overshoot less than 2%, and zero steady-state error. 
The design constraints of the microvolumetric sampler are discussed, including 
multiplicity and size of sample effect on the controller implementation. After outlining the 
performance of the device, the microvolumetric sampler device is integrated with an organ-
on-a-chip platform [43] to demonstrate the robust high-precision sampling of drug dosages. 
The analysis of cellular drug/compound loading is extended by computationally assessing 
the effect of membrane porosity. 
4.1 Microvolumetric Sampler Development 
To develop the automated microvolumetric sampler device (Figure 4.1) for high 
precision temporal and volumetric control of biological samples, the rotary motor 
integrated with the PDMS microvolumetric sampler and syringe pump systems was first 
designed and fabricated. The approach of the device was to allow researchers to set the 
desired volume of a sample at discrete time points without the introduction of human 
variation, a potential source of error or variation across repeated studies. The accuracy of 
the device will be reliant on the flow control system (i.e., syringe pump or pressure control 
system) and the precision operation of the sampling device. Because most of the 
microfluidic field utilizes syringe pumps, the developed feedback pressure control system, 
described in Chapter 2, was not used.  
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Figure 4.1 Sampling Device Schematic and Integration 
In addition to precision sampling, the design allows for researchers to sample 
biological agents in a microfluidic device, commonly used for organ-on-a-chip [43]. The 
design of the chip contains an upper and lower channel separated by a porous membrane 
(Figure 4.2).  
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Figure 4.2 Integrated Organ-on-a-chip Schematic 
To accurately measure these biological samples, the microvolumetric sampler is 
automatically rotated at specific intervals based on the desired volume and output flow rate 
of the system (Figure 4.3). Where the time to fill each well (𝑇𝑇𝑤𝑤𝑒𝑒𝑤𝑤𝑤𝑤) is dependent on both 
well volume and desired flow rate (𝑄𝑄𝑑𝑑). The overall apparatus was designed to incorporate 
microvolumetric samplers with larger sample volumes and/or multiplicity of samples, 
allowing for broader range of research applications. The basis for the performance of the 
microvolumetric sampler relies on the precision of the motor to accurately rotate the system 
while minimizing overshoot and settling time.  
 
 
Figure 4.3 Sampling Device Operation Schematic 
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4.1.1 Controller Development  
For the development of the motor dynamics and requirements, the properties of the 
microvolumetric sampler are first analyzed. The microvolumetric sampler can be expanded 
to include either larger/smaller wells a larger/smaller multiplicity of wells, generating 
design constraints by modifying both the sample volume and experimental duration. The 
maximum allowable angle between wells and the calculation of the time differential 
(Figure 4.4), based on cylindrical wells, are both used as initialization inputs for the 
microcontroller for proper functionality. The use of a circular cross-section at the surface 
of the microvolumetric sampler maximizes the area for sampling. By centering the needle 
in the center of the circular cross-section, the possibility of either the sample missing the 
well or the rotation overshooting a well is greatly reduced. Because of the circular cross-
section of the well, the design of the well can be modified to account for desired sample 
volume by either implementing cone or round bottom cylindrical geometry without the 
need to redesign the controller. 
 
Figure 4.4 Microvolumetric sampler Mathematical Constraints 
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The requirements of the controller were determined to be less than 0.3 setting time, 
less than 2% overshoot, and zero steady state error. These requirements were chosen to not 
overshoot a well, leading to potential sample deposit in an undesired well, and to remove 
compound error, potential overshoot over long experimental duration. The design of the 
controller is reliant on feedback from the encoder (28) for precision movement (Figure 
4.5). The encoder dynamics include unity gain (𝐾𝐾=1) and a sampling time (𝑇𝑇𝑠𝑠𝑓𝑓𝑚𝑚𝑝𝑝) of 




≅ 1 (28) 
   
Figure 4.5 Motor Control Block Diagram  
To develop an appropriate controller for the precision rotation of the motor, a type 1 
transfer function model (29) was first analyzed in Matlab/Simulink®, based on the 







𝐽𝐽𝑅𝑅𝑓𝑓𝑠𝑠 + 𝑏𝑏𝑅𝑅𝑓𝑓 + 𝐾𝐾𝜏𝜏𝐾𝐾𝑏𝑏
 (29) 
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where 𝐾𝐾𝜏𝜏 represents the motor-torque constant, 𝐽𝐽 represents the moment of inertia of 
the motor, 𝑅𝑅𝑓𝑓 represents the armature resistance, b represents viscous friction between the 
shaft and bearing, and 𝐾𝐾𝑏𝑏 represents the back-emf (electro-magnetic force) constant. The 
values used for the simulation are summarized in Table 4.1. 
Table 4.1 Summary of Sampling Device Modeling Parameters 
PARAMETER VALUE 
𝐽𝐽 783.99 (kgm2/rad) 
𝑏𝑏 100 (Nms/rad) 
𝑅𝑅𝑓𝑓 9.8 (Ohm) 
𝐾𝐾𝜏𝜏 1.65E+5 (Nm/amp) 
𝐾𝐾𝑏𝑏 9.8E-2 (Vs/rad) 
 
The addition of the integrator inherent to the model dynamics allows for the 
elimination of the steady state error in response to a step input. A PD (proportional 
derivative) controller (30) was chosen to add a zero to the transfer function, allowing for 
tunability of the transient response. The single integrator of the open-loop gain (𝐶𝐶 ∙ 𝐺𝐺) does 
not eliminate error associated with an external disturbance. To account for any significant 
disturbances to the system, the error can be eliminated with the use of a PI (proportional 
integrative) or PID (proportional integrative derivative) controllers by introducing an 
additionally integrator. Alternatively, the use of either a lead or lag compensators can allow 
researchers to maintain the error below a desired threshold.   
 𝐶𝐶(𝑠𝑠) = 10(1 + 0.3𝑠𝑠) (30) 
From the analysis of the simulated responses of the system, the overall overshoot from 
46% in the uncompensated system is reduced to less than 1% in the compensated system. 
The inherent integrator in the system dynamics eliminates the steady state error in both 
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systems, while the settling time is reduced to 0.06 seconds from 3 seconds (Figure 4.6) for 
the compensated and uncompensated systems, respectively.  
 
Figure 4.6 Simulated Sampling Device Motor Control 
The controller was integrated into an Arduino microcontroller with desired 𝑇𝑇𝑤𝑤𝑒𝑒𝑤𝑤𝑤𝑤 
specified based on desired well volume and desired flow rate, 𝑄𝑄𝑑𝑑. By analyzing the 
response of the physical system (Figure 4.7), both the settling time and overshoot remain 
within the design parameters at 0.3s and 1%, respectively. The response of the physical 
system achieves steady state within 2-degree of the desired target for the full 360o rotation 
indicating the presence of an external disturbance to the system, potentially from the motor 
belt. Because the sampling deposition is in the center of each well and is consistent at each 
step, the 2-degree variation has no impact on the performance of the system, because there 
is a 12.5-degree distance from the center to edge of a well. The increase in settling time 
from 0.06s to 0.3s from the simulation to physical can be attributed unmodeled nonlinear 
dynamics (e.g., bearing friction and belt slack) not present in our simulation.  The motor 
dynamics were experimentally found to have a minimum settling time of 0.3s at 100% duty 
cycle, indicating a limitation of the overall system. 
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Figure 4.7 Experimental Sampling Device Controller Performance 
To illustrate the effect of adding an additional integrator into the system to eliminate 
disturbances, a PI (proportional integrative) controller (31) was experimentally designed 
and evaluated. The small integrative gain (Ki) used in the controller is a result of the duty 
cycle control of the motor. High Ki will lead to oscillatory behavior for the first step as the 
integrative error is accumulated during the “windup” period. To avoid this behavior, the 
gain is reduced while eliminating both the oscillations and steady-state error. The steady-
state error of the response is reduced from 8% to less than 2% for the PD and PI controllers, 
respectively. The small error observed can be a combination of the belt slack and encoder 
resolution. A small increase in the settling time by 0.05s using the PI controller (Figure 
4.8) was observed. With the controller designed and implemented within the desired design 
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Figure 4.8 Sampling System Controller Comparison 
Although the PI controller reduces the steady-state error with a slightly slower settling 
time, the PD controller was implemented on the physical system because of the 12.5-degree 
variance allowed with the microvolumentric sampler. When redesigning the 
microvolumetric sampler to increase the multiplicity or wells, the steady-state error may 
become more critical to the proper operation requiring the PI controller. To overcome the 
decrease in settling time and to possible improve the steady-state error response or the PI 
controller, a bang-bang controller could potentially be developed but requires a more 
comprehensive model to appropriately design.  
4.1.2 System Performance 
To properly analyze the sampling performance, the constraint of connective tubing 
volume from the syringe pump to the sampling control device (Figure 4.9) needs to be 
considered. The fluidic time delay, T, is calculated from the syringe to the microvolumetric 
sampler based on the total volume, 𝑉𝑉𝑑𝑑𝑜𝑜𝑑𝑑, and the desired flow rate, 𝑄𝑄𝑑𝑑. For this system, the 
total volume was found to be approximately 200 µL with a desired flow rate of 20 µL/min, 
leading to a 10 min delay. 
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Figure 4.9 Sampling Fluidic Time Delay Diagram 
To assess the accuracy of the microvolumetric sampler, the ability of the device to 
sample the desired volume (100 µL) at three different flow rates (i.e., 5, 20, 100 µL/min) 
generated by a syringe pump (Figure 4.10) was first examined. For flow rates greater than 
20 µL/min, the system demonstrated high reproducibility with less than 5% error from the 
desired value. This discrepancy can partially be associated with the use of a needle/droplet 
for sampling. The formation and release of the droplet imposes a time delay on the system 
and by increasing the flow rate, the time delay can be reduced, achieving higher accuracy. 
The 5 µL/min flow rate demonstrated a long transient time approaching the desired flow 
rate due to the syringe pump performance, a potential limitation of the syringe pump [89, 
92, 93].  
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Figure 4.10 Sampling Device Accuracy Based on Flow Rate 
To decrease the variability of the microvolumetric sampler, the PDMS 
microvolumetric sampler was oxidative plasma cleaned to create a hydrophilic surface 
(Figure 4.11). This allows for the sample to be wicked into the well, reducing the probably 
of missing the well. The sampled volume was found to have an average error of 5.86% and 
2.14% for the non-plasma cleaned (control) and plasma cleaned microvolumetric sampler, 
respectively. The significant increase in the accuracy of the sampling volume indicates the 
necessity of plasma cleaning to achieve high-precision sampling. 
 
Figure 4.11 Microvolumetric Sampler Plasma Oxidation Performance 
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4.1.3 Continuous Sampling Approach 
The approach taken for the sampling was through the discretization of the sample. 
Using fluidic circuit analogs and assuming each sampling well with equivalent pressure 
differentials, the channel dimensions of each circuit can be designed (Figure 4.12). 
    
Figure 4.12 Continuous Sampling Circuit Diagram 
At each of the sampling wells the fluid flow is divided between q1 and q2, reducing the 
overall flowrate is reduced for the subsequent well. By calculating the q2 flow rate and 
knowing the channel dimensions, the temporal differential between the wells can be 
calculated which can be tuned based on the inlet flow, Q (Figure 4.13). The design of the 
system is more consistent with longer experimental duration because the inverse 
relationship to Q makes the overall system sensitive to lower flowrates.  
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Figure 4.13 Continuous Sampling Time Differential 
The constraints of the both the well volume and the temporal differential for each well 
increases the complexity of the design. Acting as a current divider, each of the microfluidic 
samplers needs to be individually designed while reducing the channel dimensions (i.e., 
resistances) to maintain consistent results. This process can be iteratively tuned with 
computational software (i.e., Matlab) by assuming parameters such as channel widths and 
channel height, leaving only the channel lengths to be calculated (Figure 4.14). Where the 
side chain length is the distance to the microfluidic well and the inter-sampler length is the 
distance between each microfluidic sampler. The profile of each length is nonlinear with 
the final value approaching a length of zero as the number of wells is increased. 
 
Figure 4.14 Simulated Continuous Microvolumetric Sampler Design 
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The continuous design, although theoretically possible, is not well suited for biological 
experimentation. The q2 flowrate does not reach zero at steady-state, leading the well to 
have a continuous inflow of sample. This causes the first well to be a mixture of the entire 
experimental duration, with the final well being the initial time differential; clouding 
experimental results. The complexity of the design, with each well beginning individually 
calibrated, greatly reduces the versatility of the platform, requiring a redesign of the entire 
device for any change in either multiplicity of samples or volume of samples. For these 
reasons, the initial conceptual design was not experimentally validated, and the discretized 
system was developed. For the application to microfluidic systems, the discretized 
sampling device was integrated for experimental validation.  
4.2 Application for Micro-Engineered Systems 
Microfluidic sampling for biological systems is critical to high-precision and 
repeatable experimentation. To examine the capability of sampling with micro-engineered 
systems, the microvolumetric sampler device is integrated with the organ-on-a-chip device 
[43]. The drug/compound concentration availability across the porous membrane is, 
additionally, analyzed with CFD at various Re and porosities, a critical understanding for 
biological experiments. 
4.2.1 Convective Flow Profiles 
Two parallel syringe pumps, connected via a t-connection, to produce two separate 
flow profiles across the porous membrane (Figure 4.15). The first profile examines 
decrease in concentration over time, analyzing the sensitivity of the system to examine a 
drug/compound over a time, a critical operation for biological systems. The second profile 
examines the reconstitution of the drug/compound within the device, an important measure 
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for use of cyclic administration of dosages. Each flow profiles were examined with varied 
pulse of the drug/compound (i.e., 1, 2, 5, and 10 min durations), to examine the effect on 
longer duration effect of drug/compound availability over time and the degree to which the 
drug/compound concentration can be reconstituted.  
 
Figure 4.15 Sampling Convective Experiment Schematic 
The flow rate dependability on the drug/compound availability (Figure 4.16) based on 
a 10 min duration of the second profile was first examined. When the flow rate is 
substantially increased, from Re of 2 (1x) to 35 (16x), the concentration fails to reach 0 
within the same time frame. The two species of both drug/compound mix more thoroughly 
with the water at higher flow rates, indicating that convective mixing is occurring across 
the membrane. This mixing causes the time constant, to reach an equivalent 0 
concentration, to be increased. At lower flow rates (i.e., Re 2), the mixing of the two species 
is primarily dominated by diffusion decreasing the amount of mixing between the 2 
species. When considering the flow rate used in experimentation, in addition to shear 
stresses, cyclic drug loading is affected by flow rates, potentially modifying experimental 
results across repeated runs. 
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Figure 4.16 Flow Rate Comparison of Convective Experiment 
To assess the effect of the various pulse durations on the reconstitution of the 
drug/compound concentration, the experiment was repeated with two separate 
concentrations (i.e., 1 and 2 mg/mL Nile Blue) at Re 2 to examine the consistency of the 
device at separate concentrations (Figure 4.17). Longer pulse durations demonstrated 
longer setting time, for the first profile, and a larger reconstitution of the drug/compound 
concentration, for the second profile. Increases in the concentration are consistent with the 
pulse input, demonstrating the sensitivity of the microvolumetric sampler device to 
measure the response (black) of an input profile (red). By understanding the concentration 
distribution over time in an organ-on-a-chip device, researchers can better model and 
predict drug/compound administration to cells, a critical operation for biological systems 
to remain physiologically relevant. By halving the concentration, the differences between 
the 1 and 2 min pulse negligible when observing the first profile response; however, the 
recovery of the drug concentration remains higher as previously observed with the full 
concentration. The use of 100 µL well sizes in the microvolumetric sampler can be tuned 
to decrease overall volume, affecting the time per well and experiment duration. More 
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importantly, decreasing well size allows for a larger multiplicity of sampling that can 
resolve the differences between the 1 and 2 min pulse durations.  
 
Figure 4.17 Effect of Pulse Duration on Drug/Compound Concentration 
4.2.2 Static Membrane Mass Transport Simulations 
To better understand the mass fraction properties within the microfluidic device, the 
drug/compound transport across the membrane with a static (no flow) lower channel and 
various Re in the upper channel (Figure 4.18 (left)) was analyzed. As the flow rate is 
increased in the upper channel, both the time constant and settling time of the lower channel 
mass fraction are decreased as the upper channel flow is increased (Figure 4.18 (right); 
Table 4.2).  
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Figure 4.18 Static Membrane Diffusion Simulation 
Due to the pressure differential in the upper channel to generate the various flow 
conditions, a pressure differential across the membrane develops, driving drug/compound 
from the upper to the lower channel. This phenomenon is in addition to diffusive forces 
acting between the two species. The larger the Re, the larger the pressure differential 
leading to greater flow across the membrane and faster coalescence, indicated by faster 
time constant and settling times. Notably, the mass fraction of the no flow condition in the 
upper channel reaches a steady-state value of 0.72, because there is a finite availability of 
drug/compound in the upper channel (e.g., static transwell). Whereas, in the flow 
conditions, an infinite amount of drug/compound is available allowing for a final mass 
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NO FLOW 0.38 1.63 
RE 0.1 0.37 1.45 
RE 1 0.28 1.16 
RE 10 0.25 1.03 
This analysis is essential for the defining the initial conditions of the microfluidic 
platforms. This is illustrated by looking at the differences between the transient responses 
of each upper flow condition at 20s (Figure 4.19). There is a gradual increase in the 
concentration of the lower channel as the flow rate is increase in the upper channel, with 
none of the conditions having equivalent fractions. 
 
Figure 4.19 Transient Membrane Mass Transport 
Increasing the time to 120s (Figure 4.20), the steady-state conditions of each of the 
channels with no discernable differences between the three flow cases. When designing the 
initial conditions of any microfluidic system, it is important to understand the effect of the 
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pressure differential caused between two separate channels. To continue the understanding 
of the mass transport of drug/compound across the membrane, the lower channel mass 
fraction is simulated when both the upper and lower channels have flow, causing a zero-
pressure differential across the membrane and relying solely on diffusive forces for mass 
transport. 
 
Figure 4.20 Steady-State Membrane Mass Transport  
4.2.3 Membrane Porosity Effect on Mass Transport 
To better understand the effect within the microfluidic device, the transport of 
drug/compound across the porous membrane with various Re (0.1, 1, and 10) and 
membrane porosity (0.05, 0.5, and 1) by creating simultaneously flows in the upper and 
lower channels (Figure 4.21) was modeled. 
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Figure 4.21 Membrane Porosity Mass Transport Simulation Schematic 
Examining the effect of the porosity of the membrane (Figure 4.22), it was observed 
that as the porosity decreased, indicative of a higher resistance to flow, the concentration 
of the lower channel decreases at steady-state. This is consistent with an electrical analog 
characterization of the membrane through the Hagan-Poiseuille equation [88], where the 
higher resistance impedes flow given equivalent pressure differentials. To better observe 
the properties with regards to cellular applications, the mass fraction to the Re, shear stress, 
and flow rate are compared. By increasing the porosity of the membrane, the transition in 
the mass fraction was found to be nonlinear with higher sensitivity at higher porosities. The 
average shear stress for arterioles and capillaries is on the range of 40-60 dyne/cm2 and 
lower in large arteries and venules, on the range of 10-20 dyne/cm2 [134]. For the device 
used, this is on the range of Re of 2 to 3 for the large arteries and venules. Due to the 
nonlinear nature of the mass fraction at various porosities, to generate physiologically 
relevant studies it is critical to analyze the membrane’s effect on the mass fraction to ensure 
proper drug/compound administration. 
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Figure 4.22 Lower Channel Steady-State Mass Fraction 
Analyzing the effect of the Re on the lower channel mass fraction, longer transient 
times due to the bulk flow overcoming the diffusive forces (Figure 4.23) when Re is 
increased are observed. Interestingly, although the flow was calculated to eliminate a 
pressure differential between the upper and lower channels, for the porosities of 1 and 0.5 
the overall concentration is increased as the Re increased. This indicates that the upper and 
lower pressure differentials may not be equivalent, generating a flow across the membrane. 
Whereas when the porosity is decreased to 0.05, no flow across the membrane occurs 
because the resistance is large enough to impede flow and diffusive forces become 
dominant. The flow and membrane properties are an integral part to properly developing 
biological microfluidic systems, to ensure proper administration of drug/compounds. 
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Figure 4.23 Lower Channel Mass Fraction Distribution 
4.3 Conclusions 
A tunable low-cost high-precision sampling device for integration with microfluidics 
through a feedback-controlled microvolumetric sampler has been developed. The robust 
controller design, including the versatility of the microvolumetric sampler design, and the 
necessity of plasma cleaning for optimal performance were demonstrated. The sensitivity 
of the sampling device was assessed to evaluate proper administration of 
drugs/compounds, and the system was shown to be able to respond to a desired input 
profile. The drug/compound concentration of both the porosity of the membrane and the 
Re of the fluid through computational analysis were evaluated, finding a necessity to 
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examine membrane properties because of nonlinear behavior and convective mixing 
attributed to membrane porosity. The tunable high-precision sampling device and 
computational analysis of membrane properties can be used to improve organ-on-a-chip 
studies, mimicking physiologically relevant values, while providing versatility for a 
broader range of applications including chemical synthesis, nanoparticle formation, and 
other microfluidic studies. 
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Chapter 5 Denouement 
The fields of micro-engineered biological systems and the pursuit of new 
nanotherapeutics have garnered increasing attention over the last few decades. A current 
challenge of these fields is that they generally reliant on chemists, biologists, and other 
aspects of life sciences to design and develop these platforms. Considerably less attention 
has been drawn to the use of engineers and, more importantly, engineering principles for 
microfluidics and biological applications. This work demonstrates, not only, the potential 
of combing the two fields but demonstrates the advantages over solely biology approaches. 
The engineering principles applied here can be broaden to aspects beyond the areas of 
pressure control, parallelization, and sampling, to the design of new microfluidic platforms 
or design modular microfluidic platforms. This integration allows for precision designed 
microfluidic channels for various applications which can be used to develop microfluidic 
logic gates or complicated integrated fluidic circuits. 
Broader Impact 
The work demonstrated here is not only limited to the applications that have been 
presented, giving researchers versatility. The feedback pressure control system can be 
broadened beyond use for microfluidic nanoparticle synthesis, to be able to control organ-
on-a-chip flow. The ability to prescribe an arbitrary pressure input profile allows for 
researchers to have the versatility to pursue various flow conditions and recreate 
physiologically relevant flows (e.g., ventricle pressure curves for vasculature-on-a-chip or 
pulmonary artery-on-a-chip). The pressure range of the profile is dependent on the pressure 
sensor integrated in the system, and, by changing out the sensor, researchers can customize 
both the range and resolution of the of the pressure response can be adjusted. This only 
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requires the PI controller to be tuned, ensuring similar performance to the work 
demonstrated in Chapter 2.  
The parallelized microfluidic array developed in Chapter 3 can be extended to devices 
beyond the swirling microvortex reactor (SMR). The method of analyzing the critical 
components to nanoparticle size and quality to design about applies to any microfluidic 
nanoparticle platform. The limitation of only 2-inlets was not widely discussed, but the 
simplicity of the design was because of the 2-inlet SMR. Extending the device to 3 or more 
inlets does not require a large redesign or a new complicated model. Because the SMR 
inlet resistance is over a thousand-fold increase over the outlet resistance, the inter-inlet 
sensitivity is essentially negligible [135]. Maintaining this property for 3 or more inlets 
allows researchers to stack PMA systems on top of one another, with rotations, to obtain 4 
or 6 inlet devices. Each layer would require additional gaskets and to allow for numerous 
connections, the distance between the reactors needs to potentially be increased. By 
increasing the microfluidic reactor channel lengths, the Z2:Z3 ratio needs to be considered, 
maintaining reactor consistency.  
Being able to design for multi-inlet microfluidics, opens the possibility of modularity 
for large scale manufacturing. Creating a universal outlet and parallelized network design, 
the system can be designed to switch out the microfluidic device. For an arbitrary design, 
the generalized microfluidic width and length create a design constraint on the 
parallelization This simplifies the process for using platforms not necessarily for LPNP as 
described in Chapter 3 but for either other NP or chemical syntheses, and from a 
manufacturing perspective, saves overall cost by minimizing the required or components 
needing to be fabricated.  
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The sampling device developed in Chapter 4 can be integrated with any microfluidic 
platform from the organ-on-a-chip device discussed or for even NP synthesis. The device 
can be further refined to include a 3-way actuated valve to sample in discretized intervals 
as opposed to the continuous model presented. This adds increasing complexity to ensure 
the proper volume and time point are deposited into the well because of the dead volume 
within the valve and, in this case, needle connection. This can be overcome by clearing the 
dead volume with either water or a new sample, but in either case the sample properties 
are skewed through mixing of the two separate species. This additionally requires a 
modified control algorithm to rotate to a waste well, potentially effecting system 
performance. For long term experimental duration, sample evaporation can potentially lead 
to experimental variation and needs to be assessed for other applications. 
Overall, each of the methods and technologies here can be expanded far beyond what 
was developed in this work allowing for versatility. By using the tools and understanding 
each of the principles used to develop each platform, the technology can be modified while 
maintaining the superior performance. Achieving a cross between classical engineering 
principles and biological platforms, the work will continue to evolve and accelerate the 
advancement of each field.   
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